The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To investigate oncological outcomes based on bladder cuff excision (BCE) during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma(UTUC) and to provide clinical evidence of tumor recurrence in patients without BCE. Materials and Methods: We retrospectively collected data of 372 consecutive patients who underwent RNU at our institution from May 1989 through October 2010. After excluding some data, we reviewed 336 patients for the analysis. Results: Of the patients who underwent RNU with BCE (n=279, 83.0%) and without BCE (n=57, 17.0%), patients without BCE had poorer cancer-specific and overall survival rates. Among 57 patients without BCE, 35 (61.4%) experienced tumor recurrence. Recurrence at the remnant ureter resulted in poor oncological outcomes compared to those in patients with bladder recurrence,but better outcomes were observed compared to recurrence at other sites. No significant predictors for tumor recurrence at the remnant ureter were identified. In patients without BCE, pathological T stage [hazard ratio (HR), 5.73] and lymphovascular invasion (HR, 3.65) were independent predictors of cancer-specificsurvival, whereas age (HR, 1.04), pathological T stage (HR, 5.11), and positivetumor margin (HR, 6.50) were independent predictors of overall survival. Conclusion: Patients without BCE had poorer overall and cancer-specific survivalafter RNU than those with BCE. Most of these patients experienced tumor recurrenceat the remnant ureter and other sites. Patients with non-organ confined UTUC after RNU without BCE may be considered for adjuvant chemotherapy with careful follow-up.
Abstract
Purpose: To investigate oncological outcomes based on bladder cuff excision (BCE) during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma(UTUC) and to provide clinical evidence of tumor recurrence in patients without BCE. Materials and Methods: We retrospectively collected data of 372 consecutive patients who underwent RNU at our institution from May 1989 through October 2010. After excluding some data, we reviewed 336 patients for the analysis. Results: Of the patients who underwent RNU with BCE (n=279, 83.0%) and without BCE (n=57, 17.0%), patients without BCE had poorer cancer-specific and overall survival rates. Among 57 patients without BCE, 35 (61.4%) experienced tumor recurrence. Recurrence at the remnant ureter resulted in poor oncological outcomes compared to those in patients with bladder recurrence,but better outcomes were observed compared to recurrence at other sites. No significant predictors for tumor recurrence at the remnant ureter were identified. In patients without BCE, pathological T stage [hazard ratio (HR), 5.73] and lymphovascular invasion (HR, 3.65) were independent predictors of cancer-specificsurvival, whereas age (HR, 1.04), pathological T stage (HR, 5.11), and positivetumor margin (HR, 6.50) were independent predictors of overall survival. Conclusion: Patients without BCE had poorer overall and cancer-specific survivalafter RNU than those with BCE. Most of these patients experienced tumor recurrenceat the remnant ureter and other sites. Patients with non-organ confined UTUC after RNU without BCE may be considered for adjuvant chemotherapy with careful follow-up.
참고문헌 (24)
- Kirkali Z, "Transitional cell carcinoma of the ureter and renal pelvis", Crit Rev Oncol Hematol, 47, pp.155~169 (2003)
- Kirkali Z, "Bladder cancer: epidemiology, staging and grading, and diagnosis", Urology, 66(6 Suppl 1), pp.4~34 (2005)
- Munoz JJ, "Upper tract urothelial neoplasms: incidence and survival during the last 2 decades", J Urol, 164, pp.1523~1525 (2000)
- Siegel R, "Cancer statistics, 2013", CA Cancer J Clin, 63, pp.11~30 (2013)
- Booth CM, "Urothelial carcinoma of the kidney and ureter", Br J Urol, 52, pp.430~435 (1980)
- McCarron JP, "Tumors of the renal pelvis and ureter: current concepts and management", Semin Urol, 1, pp.75~81 (1983)
- Rouprêt M, "European guidelines on upper tract urothelial carcinomas: 2013 update", Eur Urol, 63, pp.1059~1071 (2013)
- Srirangam SJ, "Laparoscopic nephroureterectomy : the distal ureteral dilemma", Adv Urol, pp.316807~ (2009)
- Zlotta AR, "Should urologists always perform a bladder cuff resection during nephroureterectomy, and which method should they use?", Eur Urol, 57, pp.970~972 (2010)
- Lughezzani G, "Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study", Eur Urol, 57, pp.956~962 (2010)
- Lughezzani G, "Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients", Eur J Cancer, 45, pp.3291~3297 (2009)
- Hou CP, "Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma", Chang Gung Med J, 34, pp.496~505 (2011)
- Cha EK, "Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma", Eur Urol, 61, pp.818~825 (2012)
- Jeldres C, "Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter", J Urol, 183, pp.1324~1329 (2010)
- Fairey AS, "Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration", BJU Int, 112, pp.791~797 (2013)
- Hung SY, "Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer", Int Urol Nephrol, 46, pp.921~926 (2014)
- Ko R, "Transitional-cell carcinoma recurrence rate after nephroureterectomy in patients who undergo open excision of bladder cuff v transurethral incision of the ureteral orifice", J Endourol, 21, pp.730~734 (2007)
- Abel EJ, "Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes", Int Braz J Urol, 39, pp.817~822 (2013)
- Huben RP, "Tumor grade and stage as prognostic variables in upper tract urothelial tumors", Cancer, 62, pp.2016~2020 (1988)
- Oosterlinck W, "EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma", Eur Urol ;, 46, pp.147~154 (2004)
- Oikawa T, "A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter", Hinyokika Kiyo, 47, pp.237~240 (2001)
- Colin P, "Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study", BJU Int, 110, pp.1134~1141 (2012)
- Espiritu PN, "Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection", Urol Oncol, 32, pp.619~624 (2014)
- Margulis V, "Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract", J Urol, 184, pp.453~458 (2010)